Omas, Baby Boy .

HRN: 28-84-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/17/2026
04/24/2026
IV
26.5MG
Q24
PSB
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: